Line Schmidt Tarpgaard

5PUBLICATIONS
31CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 05, 2026
Neoadjuvant Single-Cycle Pembrolizumab for Stage I-III MMR-Deficient Colon Cancer: The RESET-C Trial.

|Sep 15, 2025
New dosing schedules in pre-treated patients with metastatic colorectal cancer.

Per Pfeiffer, Line Schmidt Tarpgaard

|Jan 11, 2024
Treatment Options in Late-Line Colorectal Cancer: Lessons Learned from Recent Randomized Studies.

Line Schmidt Tarpgaard, Stine Brændegaard Winther, Per Pfeiffer

|Mar 30, 2021
New use for old drugs: Epirubicin in colorectal cancer.

Line S Tarpgaard, Camilla Qvortrup, Signe L Nielsen

|Oct 08, 2020
Quality of life in patients with cancer during the COVID-19 pandemic - a Danish cross-sectional study (COPICADS).

Stefan S Jeppesen, Kristian K Bentsen, Trine L Jørgensen

Pageof 1